287 related articles for article (PubMed ID: 36901719)
1. Chitosan Nanoparticles as Oral Drug Carriers.
Guadarrama-Escobar OR; Serrano-Castañeda P; Anguiano-Almazán E; Vázquez-Durán A; Peña-Juárez MC; Vera-Graziano R; Morales-Florido MI; Rodriguez-Perez B; Rodriguez-Cruz IM; Miranda-Calderón JE; Escobar-Chávez JJ
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901719
[TBL] [Abstract][Full Text] [Related]
2. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
Chaudhury A; Das S
AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
[TBL] [Abstract][Full Text] [Related]
3. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
4. Chitosan in Oral Drug Delivery Formulations: A Review.
Sangnim T; Dheer D; Jangra N; Huanbutta K; Puri V; Sharma A
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765329
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
8. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
[TBL] [Abstract][Full Text] [Related]
9. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
10. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review.
Elkomy MH; Ali AA; Eid HM
J Control Release; 2022 Nov; 351():923-940. PubMed ID: 36216174
[TBL] [Abstract][Full Text] [Related]
11. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
13. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
14. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
Naskar S; Koutsu K; Sharma S
J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
[TBL] [Abstract][Full Text] [Related]
16. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
[TBL] [Abstract][Full Text] [Related]
17. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.
Ahmed TA; Aljaeid BM
Drug Des Devel Ther; 2016; 10():483-507. PubMed ID: 26869768
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
Islam N; Ferro V
Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
[TBL] [Abstract][Full Text] [Related]
20. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
